<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="119499">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02112370</url>
  </required_header>
  <id_info>
    <org_study_id>B-1403/242-006</org_study_id>
    <nct_id>NCT02112370</nct_id>
  </id_info>
  <brief_title>Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy</brief_title>
  <acronym>REBT</acronym>
  <official_title>Phase 3 Study of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the pain relief and the hemodynamic stability of ropivacaine with epinephrine in
      BABA endoscopic and robotic thyroidectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Diluted ropivacaine with epinephrine is injected into the subcutaneous space to relieve pain
      and reduce bleeding during procedures. The synergistic effect of ropivacaine with
      epinephrine can contribute to patients' welfare, such as relieving pain and structuring the
      hemodynamic stability.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change of VAS pain scores for the first 12 hours</measure>
    <time_frame>For the first postoperative 12 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>The visual analogue scale is utilized to assess the postoperative pain change for the first 12 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum of measured systolic blood pressures</measure>
    <time_frame>During operation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The maximal systolic blood pressure is monitored during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum of measured diastolic blood pressures</measure>
    <time_frame>During operation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The maximal diastolic blood pressure is monitored during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum of measured heart rates</measure>
    <time_frame>During operation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The maximal heart rate is monitored during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss amount</measure>
    <time_frame>At the end of operation</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The blood loss amount is estimated at the end of surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">148</enrollment>
  <condition>Thyroid Neoplasm</condition>
  <condition>Goiter</condition>
  <arm_group>
    <arm_group_label>Normal saline injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>200cc normal saline is injected into the subcutaneous layer for the initial flap dissection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine with epinephrine injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg/mL 1cc epinephrine is diluted in 200cc normal saline and then 7.5 mg/mL 30cc ropivacaine is diluted in the same normal saline. The mixture is injected into the subcutaneous layer for the initial flap dissection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine with epinephrine injection</intervention_name>
    <description>According to the Ministry of Health and Welfare, ropivacaine is classified as no. 121- local analgesic and epinephrine as no. 245- adrenal hormone drug.</description>
    <arm_group_label>Ropivacaine with epinephrine injection</arm_group_label>
    <other_name>Hanlim ropiva injection 7.5 mg/mL (20cc)</other_name>
    <other_name>Insurance code: A37804211</other_name>
    <other_name>Jeil epinephrine injection 1 mg/mL (1cc)</other_name>
    <other_name>Insurance code: A04900341</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of thyroid neoplasm or benign goiter

          -  Scheduled for BABA endoscopic or robotic thyroidectomy

        Exclusion Criteria:

          -  Completion thyroidectomy

          -  Modified radical neck dissection

          -  Allergy history

          -  Stroke history

          -  Uncontrolled hypertension

          -  Uncontrolled diabetes

          -  Coagulopathy

          -  Severe cardiovascular disease

          -  Severe pulmonary disease

          -  Chronic kidney disease

          -  Pregnant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyu Eun Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yong Joon Suh, MD</last_name>
    <phone>83-10-4534-6126</phone>
    <email>nicizm@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yong Joon Suh, MD</last_name>
      <phone>82-10-4534-1626</phone>
      <email>nicizm@gmail.com</email>
    </contact>
    <investigator>
      <last_name>June Young Choi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kyu Hyung Kim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jun Woo Jung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yong Joon Suh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yong Joon Suh, MD</last_name>
      <phone>82-10-4534-6126</phone>
      <email>nicizm@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kyueun Lee, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Su-jin Kim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hyungju Kwon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.frca.co.uk/article.aspx?articleid=100816</url>
    <description>Pharmacology of regional anaesthesia</description>
  </link>
  <reference>
    <citation>Hristovska AM, Kristensen BB, Rasmussen MA, Rasmussen YH, Elving LB, Nielsen CV, Kehlet H. Effect of systematic local infiltration analgesia on postoperative pain in vaginal hysterectomy: a randomized, placebo-controlled trial. Acta Obstet Gynecol Scand. 2013 Dec 16. doi: 10.1111/aogs.12319. [Epub ahead of print]</citation>
    <PMID>24576202</PMID>
  </reference>
  <reference>
    <citation>Miratashi SA, Behdad S, Ayatollahi V, Ahmadi A. Hemodynamic effects of intraocular epinephrine during cataract surgery: a double blinded placebo controlled randomized clinical trial. Nepal J Ophthalmol. 2012 Jul-Dec;4(2):288-94. doi: http://dx.doi.org/10.3126/nepjoph.v4i2.6546.</citation>
    <PMID>22864036</PMID>
  </reference>
  <reference>
    <citation>Kim SJ, Lee KE, Myong JP, Koo do H, Lee J, Youn YK. Prospective study of sensation in anterior chest areas before and after a bilateral axillo-breast approach for endoscopic/robotic thyroid surgery. World J Surg. 2013 May;37(5):1147-53. doi: 10.1007/s00268-013-1934-8.</citation>
    <PMID>23397168</PMID>
  </reference>
  <reference>
    <citation>Lee KE, Choi JY, Youn YK. Bilateral axillo-breast approach robotic thyroidectomy. Surg Laparosc Endosc Percutan Tech. 2011 Aug;21(4):230-6. doi: 10.1097/SLE.0b013e31822d0455.</citation>
    <PMID>21857470</PMID>
  </reference>
  <reference>
    <citation>Choe JH, Kim SW, Chung KW, Park KS, Han W, Noh DY, Oh SK, Youn YK. Endoscopic thyroidectomy using a new bilateral axillo-breast approach. World J Surg. 2007 Mar;31(3):601-6.</citation>
    <PMID>17308853</PMID>
  </reference>
  <reference>
    <citation>Choi JY, Lee KE, Chung KW, Kim SW, Choe JH, Koo do H, Kim SJ, Lee J, Chung YS, Oh SK, Youn YK. Endoscopic thyroidectomy via bilateral axillo-breast approach (BABA): review of 512 cases in a single institute. Surg Endosc. 2012 Apr;26(4):948-55. doi: 10.1007/s00464-011-1973-x. Epub 2011 Nov 4.</citation>
    <PMID>22052422</PMID>
  </reference>
  <reference>
    <citation>Kwon H, Koo do H, Choi JY, Kim E, Lee KE, Youn YK. Bilateral axillo-breast approach robotic thyroidectomy for Graves' disease: an initial experience in a single institute. World J Surg. 2013 Jul;37(7):1576-81. doi: 10.1007/s00268-013-2027-4.</citation>
    <PMID>23558759</PMID>
  </reference>
  <reference>
    <citation>Lee KE, Kim E, Koo do H, Choi JY, Kim KH, Youn YK. Robotic thyroidectomy by bilateral axillo-breast approach: review of 1,026 cases and surgical completeness. Surg Endosc. 2013 Aug;27(8):2955-62. doi: 10.1007/s00464-013-2863-1. Epub 2013 Feb 23.</citation>
    <PMID>23436099</PMID>
  </reference>
  <reference>
    <citation>Lee KE, Koo do H, Im HJ, Park SK, Choi JY, Paeng JC, Chung JK, Oh SK, Youn YK. Surgical completeness of bilateral axillo-breast approach robotic thyroidectomy: comparison with conventional open thyroidectomy after propensity score matching. Surgery. 2011 Dec;150(6):1266-74. doi: 10.1016/j.surg.2011.09.015.</citation>
    <PMID>22136850</PMID>
  </reference>
  <reference>
    <citation>Lee KE, Rao J, Youn YK. Endoscopic thyroidectomy with the da Vinci robot system using the bilateral axillary breast approach (BABA) technique: our initial experience. Surg Laparosc Endosc Percutan Tech. 2009 Jun;19(3):e71-5. doi: 10.1097/SLE.0b013e3181a4ccae.</citation>
    <PMID>19542833</PMID>
  </reference>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 24, 2014</lastchanged_date>
  <firstreceived_date>April 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Kyu Eun Lee</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Ropivacaine</keyword>
  <keyword>Epinephrine</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Robotics</keyword>
  <keyword>Thyroidectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Goiter</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
